Loading stock data...

Aarti Pharmalabs Limited

NSE: AARTIPHARM BSE: AARTIPHARM

NSE
917.25 4.60 (0.50%)

Prev Close

912.65

Open Price

913.9

Volume

128,893

Today Low / High

908.5 / 928.9

52 WK Low / High

551.05 / 949.5

Range

871 - 963

BSE
912.55 -0.05 (-0.01%)

Prev Close

912.6

Open Price

918.75

Volume

4,566

Today Low / High

908.15 / 928.55

52 WK Low / High

521 / 948.8

Range

867 - 958

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 917.25 (target range: 871 - 963), reflecting a change of 4.6 (0.50403%). On the BSE, it is listed at 912.55 (target range: 867 - 958), showing a change of -0.05 (-0.00547885%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

02 Jul 913.90 0.37%
01 Jul 898.30 1.60%
30 Jun 863.80 3.07%
27 Jun 880.95 -2.43%
26 Jun 870.75 0.24%
25 Jun 855.00 1.35%
24 Jun 884.00 -3.43%
23 Jun 849.80 2.72%
20 Jun 846.75 0.77%
19 Jun 880.90 -4.36%
18 Jun 863.45 2.01%
17 Jun 874.40 -1.74%
16 Jun 890.00 -1.76%
13 Jun 910.00 -2.68%
12 Jun 921.40 -0.34%
11 Jun 923.50 -0.72%
10 Jun 913.90 1.05%
09 Jun 921.85 -1.16%
06 Jun 929.00 -2.13%
05 Jun 939.80 -1.55%
04 Jun 908.00 2.60%

Aarti Pharmalabs Limited Graph

Aarti Pharmalabs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Aarti Pharmalabs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 917.25, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 912.55 921.68 829.51 - 1,013.84
930.80 744.64 - 1,116.96
939.93 657.95 - 1,221.90
Bearish Scenario 912.55 903.42 813.08 - 993.77
894.30 715.44 - 1,073.16
885.17 619.62 - 1,150.73

Overview of Aarti Pharmalabs Limited

ISIN

INE0LRU01027

Industry

Drug Manufacturers - Specialty & Generic

Vol.Avg

496,949

Market Cap

82,876,296,528

Last Dividend

3.5

Official Website

Visit Website

IPO Date

2023-01-30

DCF Diff

-138.48

DCF

857

Financial Ratios Every Investor Needs

Stock Dividend of AARTIPHARM

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-02-14 February 14, 25 2.5 2.5 2025-02-14 2025-03-07
2024-07-31 July 31, 24 1 1 2024-07-31 2024-09-02
2024-02-16 February 16, 24 2 2 2024-02-19 2024-03-08

Stock Rating Details for AARTIPHARM

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,115.07 Cr 1,127.88 Cr 987.20 Cr 0.4667 0.00 Cr 0.00 Cr 377.47 Cr 272.40 Cr 30.06 464.37 Cr 0.1288
2024-03-31 1,815.51 Cr 1,424.71 Cr 390.80 Cr 0.2153 8.37 Cr 138.41 Cr 312.81 Cr 216.90 Cr 23.93 390.94 Cr 0.1195
2023-03-31 1,945.23 Cr 1,531.36 Cr 413.87 Cr 0.2128 13.96 Cr 129.69 Cr 279.51 Cr 193.49 Cr 21.35 344.37 Cr 0.0995
2022-03-31 1,192.03 Cr 879.70 Cr 312.33 Cr 0.2620 0.00 Cr 1.51 Cr 164.83 Cr 122.25 Cr 13.49 197.84 Cr 0.1026
2021-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.18 0.00 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 8.65 Cr 2,906.41 Cr 916.50 Cr 1,989.9064 Cr 413.12 Cr 404.47 Cr 587.58 Cr 1,410.70 Cr 0.00 Cr 0.00 Cr 29.24 Cr 657.0495 Cr
2024-03-31 23.63 Cr 2,582.11 Cr 825.07 Cr 1,757.0400 Cr 285.25 Cr 261.62 Cr 642.86 Cr 1,105.45 Cr 0.00 Cr 0.00 Cr 36.78 Cr 694.3891 Cr
2023-03-31 12.12 Cr 2,244.02 Cr 685.54 Cr 1,558.4866 Cr 215.31 Cr 203.19 Cr 602.04 Cr 988.57 Cr 0.00 Cr 0.00 Cr -6.03 Cr 600.6234 Cr
2022-03-31 83.27 Cr 2,039.90 Cr 653.42 Cr 1,386.4778 Cr 341.40 Cr 258.13 Cr 475.45 Cr 945.31 Cr 0.00 Cr -1.00 Cr 32.23 Cr 580.6649 Cr
2021-03-31 0.25 Cr 0.25 Cr 0.02 Cr 0.2267 Cr 0.02 Cr -0.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0219 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 331.5615 Cr -413.8977 Cr 65.4350 Cr -70.4759 Cr -16.9012 Cr 6.7337 Cr -443.8784 Cr 272.4048 Cr 93.8005 Cr -31.7191 Cr 55.2790 Cr
2024-03-31 216.3546 Cr -214.5644 Cr 9.7235 Cr 17.5695 Cr 11.5137 Cr 23.6349 Cr -155.6042 Cr 216.9020 Cr 49.9934 Cr -18.1252 Cr -39.6600 Cr
2023-03-31 250.1154 Cr -157.8030 Cr -163.4646 Cr 130.4585 Cr -71.1522 Cr 12.1212 Cr -119.6569 Cr 260.7747 Cr -124.2877 Cr -18.1252 Cr -126.6600 Cr
2022-03-31 -43.7038 Cr -138.7389 Cr 260.3834 Cr -184.8558 Cr 83.0234 Cr 83.2734 Cr -141.1520 Cr 155.3804 Cr 272.3422 Cr 0.0000 Cr -55.9920 Cr
2021-03-31 0.0000 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr 0.2500 Cr 0.0000 Cr -0.0046 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 563.78 Cr 278.75 Cr 285.03 Cr 0.5056 122.81 Cr 88.34 Cr 9.75 144.54 Cr 0.1567
2024-12-31 537.78 Cr 275.31 Cr 262.47 Cr 0.4881 105.57 Cr 73.99 Cr 8.16 133.64 Cr 0.1376
2024-09-30 458.03 Cr 294.19 Cr 163.84 Cr 0.3577 72.79 Cr 54.62 Cr 6.03 98.16 Cr 0.1193
2024-06-30 555.49 Cr 397.64 Cr 157.85 Cr 0.2842 76.29 Cr 55.45 Cr 6.12 98.68 Cr 0.0998
2024-03-31 468.67 Cr 347.24 Cr 121.43 Cr 0.2591 98.40 Cr 65.25 Cr 7.20 119.55 Cr 0.1392

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 8.65 Cr 47.56 Cr 56.21 Cr 575.40 Cr 587.58 Cr 1,322.17 Cr 1,410.70 Cr 2,906.41 Cr 916.50 Cr
2024-12-31 0.00 Cr 0.00 Cr 99.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -1,856.73 Cr
2024-09-30 40.81 Cr 58.16 Cr 99.51 Cr 434.38 Cr 719.80 Cr 1,376.67 Cr 1,228.35 Cr 2,776.51 Cr 919.79 Cr
2024-06-30 -94.32 Cr 188.63 Cr 94.32 Cr 0.00 Cr 0.00 Cr 94.32 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 23.63 Cr 70.40 Cr 94.45 Cr 519.34 Cr 642.86 Cr 1,345.64 Cr 1,105.45 Cr 2,582.11 Cr 825.07 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 88.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 73.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 54.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 55.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 65.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Drug Manufacturers - Specialty & Generic

Company Name Symbol Price Market Cap Volume
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,678.80 ₹4,027,911,264,000.00 ₹660,654.00
Divi's Laboratories Limited DIVISLAB ₹6,833.00 ₹1,813,949,677,000.00 ₹113,484.00
Torrent Pharmaceuticals Limited TORNTPHARM ₹3,369.80 ₹1,140,491,961,000.00 ₹159,405.00
Dr. Reddy's Laboratories Limited DRREDDY ₹1,269.00 ₹1,055,909,190,060.00 ₹829,856.00
Zydus Lifesciences Limited ZYDUSLIFE ₹999.10 ₹1,005,324,393,000.00 ₹627,147.00
Mankind Pharma Limited MANKIND ₹2,351.00 ₹970,325,314,760.00 ₹274,891.00
Lupin Limited LUPIN ₹1,980.00 ₹904,256,100,000.00 ₹500,567.00
Aurobindo Pharma Limited AUROPHARMA ₹1,153.70 ₹670,071,267,400.00 ₹786,261.00
Alkem Laboratories Limited ALKEM ₹4,857.40 ₹580,775,031,000.00 ₹34,318.00
Glenmark Pharmaceuticals Limited GLENMARK ₹1,771.50 ₹499,919,071,500.00 ₹191,543.00
Suven Pharmaceuticals Limited SUVENPHAR ₹1,078.00 ₹412,407,234,624.00 ₹1,177,218.00
Laurus Labs Limited LAURUSLABS ₹755.10 ₹407,189,940,300.00 ₹1,952,208.00
Cohance Lifesciences Limited COHANCE ₹959.45 ₹367,053,915,826.00 ₹64,770.00
Ipca Laboratories Limited IPCALAB ₹1,380.80 ₹350,314,483,200.00 ₹45,559.00
Ajanta Pharma Limited AJANTPHARM ₹2,501.70 ₹312,492,350,400.00 ₹17,865.00
Wockhardt Limited WOCKPHARMA ₹1,691.50 ₹274,833,228,500.00 ₹268,639.00
Piramal Enterprises Limited PEL ₹1,154.50 ₹261,699,751,000.00 ₹243,711.00
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM ₹1,638.20 ₹255,655,853,800.00 ₹217,836.00
AstraZeneca Pharma India Limited ASTRAZEN ₹9,084.50 ₹227,112,500,000.00 ₹69,108.00
Eris Lifesciences Limited ERIS ₹1,639.00 ₹223,226,883,000.00 ₹40,405.00
Alembic Pharmaceuticals Limited APLLTD ₹994.10 ₹195,403,278,300.00 ₹286,377.00
Jubilant Pharmova Limited JUBLPHARMA ₹1,202.60 ₹191,551,330,600.00 ₹67,982.00
NATCO Pharma Limited NATCOPHARM ₹923.85 ₹165,470,773,500.00 ₹359,451.00
Neuland Laboratories Limited NEULANDLAB ₹11,866.00 ₹152,239,593,400.00 ₹6,969.00
Caplin Point Laboratories Limited CAPLIPOINT ₹1,966.00 ₹149,439,002,200.00 ₹81,435.00
Glenmark Life Sciences Limited GLS ₹1,086.00 ₹133,070,838,000.00 ₹130,938.00
Granules India Limited GRANULES ₹490.90 ₹119,113,939,600.00 ₹449,059.00
Procter & Gamble Health Limited PGHL ₹5,804.50 ₹96,351,217,300.00 ₹2,942.00
Shilpa Medicare Limited SHILPAMED ₹864.40 ₹84,530,453,960.00 ₹23,978.00
Aarti Pharmalabs Limited AARTIPHARM ₹917.10 ₹83,121,010,002.00 ₹128,896.00
Strides Pharma Science Limited STAR ₹877.35 ₹80,858,944,845.00 ₹199,095.00
FDC Limited FDC ₹486.30 ₹79,174,503,000.00 ₹32,692.00
Suven Life Sciences Limited SUVEN ₹247.50 ₹53,973,315,000.00 ₹77,153.00
Sun Pharma Advanced Research Company Limited SPARC ₹160.01 ₹51,926,765,220.00 ₹166,498.00
Innova Captab Limited INNOVACAP ₹847.00 ₹48,469,515,710.00 ₹14,916.00
Sequent Scientific Limited SEQUENT ₹185.60 ₹46,456,608,000.00 ₹210,398.00
Aarti Drugs Limited AARTIDRUGS ₹481.70 ₹43,964,759,000.00 ₹1,177,838.00
Hikal Limited HIKAL ₹344.85 ₹42,520,349,850.00 ₹393,071.00
Unichem Laboratories Limited UNICHEMLAB ₹588.25 ₹41,416,211,850.00 ₹9,146.00
RPG Life Sciences Limited RPGLIFE ₹2,486.60 ₹41,125,877,400.00 ₹9,383.00
Orchid Pharma Limited ORCHPHARMA ₹728.85 ₹36,966,616,035.00 ₹52,390.00
Gufic Biosciences Limited GUFICBIO ₹353.45 ₹35,443,259,100.00 ₹24,114.00
Morepen Laboratories Limited MOREPENLAB ₹61.64 ₹33,775,884,560.00 ₹911,773.00
Alembic Limited ALEMBICLTD ₹121.40 ₹31,173,334,679.00 ₹340,784.00
Solara Active Pharma Sciences Limited SOLARA ₹642.60 ₹30,943,117,800.00 ₹74,256.00
Indoco Remedies Limited INDOCO ₹323.60 ₹29,851,420,440.00 ₹45,130.00
IOL Chemicals and Pharmaceuticals Limited IOLCP ₹96.24 ₹28,249,038,480.00 ₹448,846.00

Key Executives

Senior General Manager of HR & Admin
Mr. Sudhakar Shetty

Gender: male

Year Born:

Head of API Export Regulated and R&D Management
Mr. Sachin Patil

Gender: male

Year Born:

Head of Business Development & Direct Procurement
Mr. Jasmin Mehta

Gender: male

Year Born:

MD & Director
Mr. Narendra Jagannath Salvi

Gender: male

Year Born: 1964

Vice Chairperson & MD
Ms. Hetal Gogri Gala

Gender: female

Year Born: 1975

President of R&D
Dr. B. S. Patravale

Gender: Not Specified

Year Born:

Company Secretary & Compliance Officer
Mr. Jeevan Bhargav Mondkar

Gender: male

Year Born:

Head of Operations & Manufacturing, CDMO & CMO
Mr. G.M. Naidu

Gender: male

Year Born:

Chief Financial Officer
Mr. Piyush P. Lakhani

Gender: male

Year Born:

FAQs about Aarti Pharmalabs Limited

Who is the CEO of the company?

The CEO is Hetal Gogri Gala.

What is the current market price of the stock?

The current price is ₹914.40.

What is the 52-week price range?

The range is ₹551.05-949.5.

What is the market capitalization of the company?

The market capitalization is ₹8,287.63 crores.

What is the dividend yield?

The dividend yield is 0.38%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 30.45.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Aarti Pharmalabs Limited (ISIN: INE0LRU01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹8,287.63 crores and an average daily volume of 496,949 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹3.5.